Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dental pulp mesenchymal stem cell injection for underactive bladder
IRCT20250213064719N1Phase 2Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- Jun 2025
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of dental pulp mesenchymal stem cells in Detrusor hypocontractility, sponsored by Kerman University of Medical Sciences. Primary endpoint: Urodynamic results at 6 months. Started Jun 2025; status: completed.
02
Drugs
dental pulp mesenchymal stem cells
03
Conditions
Detrusor hypocontractility
Beyond the preview
Go deeper on IRCT20250213064719N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250213064719N1.